CLEC12A and neoplasm: Hutten et al. showed that CLL-1 is also expressed on myeloid and plasmacytoid DCs, enhancing delivery of tumor antigens into DCs, resulting in efficient antigen presentation on CD8-positive T cells, which was not attenuated by CLL-1-targeted antibodies [92].